{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:03:13Z","timestamp":1787594593860,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbadis.2026.168280","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:01:34Z","timestamp":1778137294000},"page":"168280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1\/JUN"],"prefix":"10.1016","volume":"1872","author":[{"given":"Jerry","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanakaraju","family":"Manupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadid U.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168280_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2026.168280_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.897007","article-title":"Racial disparities in access to health care infrastructure across US counties: a geographic information systems analysis","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbadis.2026.168280_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.628744","article-title":"Availability, affordability, access, and pricing of anti-cancer medicines in low- and middle-income countries: a systematic review of literature","volume":"9","author":"Ocran Mattila","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbadis.2026.168280_bb0020","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.bbadis.2026.168280_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13020-025-01124-y","article-title":"Natural anti-cancer products: insights from herbal medicine","volume":"20","author":"Cui","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.bbadis.2026.168280_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47050362","article-title":"Herbal medicine in breast cancer therapy: mechanisms, evidence, and future perspectives","volume":"47","author":"Wu","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9963038","article-title":"Prevalence of the use of herbal medicines among patients with cancer: a systematic review and meta-analysis","volume":"2021","author":"Asiimwe","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbadis.2026.168280_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-024-03764-9","article-title":"Curcumin as a complementary treatment in oncological therapy: a systematic review","volume":"81","author":"Gutsche","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12032-024-02459-6","article-title":"Allicin: a promising modulator of apoptosis and survival signaling in cancer","volume":"41","author":"Bhuker","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s12672-025-02591-3","article-title":"Therapeutic role of allicin in gastrointestinal cancers: mechanisms and safety aspects","volume":"16","author":"Chauhan","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29061320","article-title":"Allicin and cancer hallmarks","volume":"29","author":"Talib","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2026.168280_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314280","article-title":"Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: a systematic review","volume":"19","author":"Abdull Rahim","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2026.168280_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbadis.2026.168280_bb0070","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bbadis.2026.168280_bb0075","article-title":"Impacts of turmeric and its principal bioactive curcumin on human health: pharmaceutical, medicinal, and food applications: a comprehensive review","volume":"9","author":"El-Saadony","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbadis.2026.168280_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051033","article-title":"A review of curcumin and its derivatives as anticancer agents","volume":"20","author":"Tomeh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168280_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-12","article-title":"Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma","volume":"10","author":"Wilken","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168280_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-019-1320-y","article-title":"Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT\/beta-catenin pathway","volume":"38","author":"Vallee","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168280_bb0095","first-page":"236","article-title":"Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors","volume":"6","author":"Kim","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbadis.2026.168280_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107613","article-title":"Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells","volume":"151","author":"Zaman","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0105","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"CYTOR facilitates formation of FOSL1 phase separation and super enhancers to drive metastasis of tumor budding cells in head and neck squamous cell carcinoma","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbadis.2026.168280_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.656628","article-title":"A super-enhancer driven by FOSL1 controls miR-21-5p expression in head and neck squamous cell carcinoma","volume":"11","author":"Wan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0115","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.21873\/anticanres.15119","article-title":"FosL1 regulates regional metastasis of head and neck squamous cell carcinoma by promoting cell migration, invasion, and proliferation","volume":"41","author":"Hyakusoku","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bbadis.2026.168280_bb0120","doi-asserted-by":"crossref","first-page":"40104","DOI":"10.1074\/jbc.C111.296707","article-title":"Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma","volume":"286","author":"Jin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.02.003","article-title":"Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2026.168280_bb0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1412","article-title":"Treatment of arthritis with a selective inhibitor of c-Fos\/activator protein-1","volume":"26","author":"Aikawa","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0135","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0140","doi-asserted-by":"crossref","first-page":"16983","DOI":"10.1038\/s41598-017-17289-y","article-title":"A selective inhibition of c-Fos\/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain","volume":"7","author":"Makino","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168280_bb0145","first-page":"195","article-title":"Drugs in clinical development for rheumatoid arthritis summary and table","volume":"28","year":"2014","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.bbadis.2026.168280_bb0150","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1007\/s11033-021-06722-1","article-title":"Allicin induces cell cycle arrest and apoptosis of breast cancer cells in vitro via modulating the p53 pathway","volume":"48","author":"Maitisha","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbadis.2026.168280_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598555","article-title":"The inhibitory effect of 6-gingerol on ubiquitin-specific peptidase 14 enhances autophagy-dependent ferroptosis and anti-tumor in vivo and in vitro","volume":"11","author":"Tsai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0160","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","article-title":"Curcumin effectively inhibits oncogenic NF-kappaB signaling and restrains stemness features in liver cancer","volume":"63","author":"Marquardt","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168280_bb0170","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jcp.29044","article-title":"Cancer stem cells: a review from origin to therapeutic implications","volume":"235","author":"Atashzar","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0175","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ymthe.2021.03.024","article-title":"FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program","volume":"29","author":"Zhang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2026.168280_bb0180","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-021-24137-1","article-title":"Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168280_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/537028","article-title":"AP1 transcription factors in epidermal differentiation and skin cancer","volume":"2013","author":"Eckert","year":"2013","journal-title":"J. Skin Cancer"},{"key":"10.1016\/j.bbadis.2026.168280_bb0190","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0092-8674(88)90146-8","article-title":"DNA binding activities of three murine Jun proteins: stimulation by Fos","volume":"55","author":"Nakabeppu","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168280_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/336646a0","article-title":"The role of the leucine zipper in the fos-jun interaction","volume":"336","author":"Kouzarides","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168280_bb0200","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.88.12.5292","article-title":"Suppression of c-Jun\/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells","volume":"88","author":"Huang","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2026.168280_bb0205","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/MCB.22.13.4952-4964.2002","article-title":"Promoter specificity and biological activity of tethered AP-1 dimers","volume":"22","author":"Bakiri","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0210","doi-asserted-by":"crossref","first-page":"40974","DOI":"10.1074\/jbc.M111.290874","article-title":"Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105812","article-title":"Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt\/beta-catenin signaling pathway","volume":"124","author":"Morris","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-06014-9","article-title":"FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168280_bb0225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11010-023-04737-9","article-title":"Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4","volume":"479","author":"Lin","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154496","article-title":"FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells","volume":"246","author":"Liu","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbadis.2026.168280_bb0235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1158\/1541-7786.MCR-21-0658","article-title":"Transcription factor FOSL1 enhances drug resistance of breast cancer through DUSP7-mediated dephosphorylation of PEA15","volume":"20","author":"Li","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168280_bb0240","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.steroids.2011.04.011","article-title":"Inhibition of FOSL1 overexpression in antiestrogen-resistant MCF-7 cells decreases cell growth and increases vacuolization and cell death","volume":"76","author":"Pennanen","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2026.168280_bb0245","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1038\/s41598-018-28672-8","article-title":"Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis","volume":"8","author":"Vsiansky","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168280_bb0250","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/cas.12914","article-title":"Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model","volume":"107","author":"Kamide","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2026.168280_bb0255","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.33501","article-title":"Inhibition of activator protein 1 signaling abrogates transforming growth factor beta-mediated activation of fibroblasts and prevents experimental fibrosis","volume":"64","author":"Avouac","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2026.168280_bb0260","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/dmd.110.037952","article-title":"Metabolism of the c-Fos\/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms","volume":"39","author":"Uchihashi","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2026.168280_bb0265","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbadis.2026.168280_bb0270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/a-1207-9469","article-title":"A comprehensive review on physiological effects of curcumin","volume":"70","author":"Ahsan","year":"2020","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.bbadis.2026.168280_bb0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fphys.2019.00633","article-title":"Curcumin\/liposome nanotechnology as delivery platform for anti-inflammatory activities via NFkB\/ERK\/pERK pathway in human dental pulp treated with 2-HydroxyEthyl MethAcrylate (HEMA)","volume":"10","author":"Sinjari","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2026.168280_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134262","article-title":"PH sensitive double-layered emulsions stabilized by bacterial cellulose nanofibers\/soy protein isolate\/chitosan complex enhanced the bioaccessibility of curcumin: in vitro study","volume":"402","author":"Shen","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.bbadis.2026.168280_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12013-020-00922-5","article-title":"An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline?","volume":"78","author":"Olotu","year":"2020","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2026.168280_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134344","article-title":"Preparation, properties and interaction of curcumin loaded zein\/HP-beta-CD nanoparticles based on electrostatic interactions by antisolvent co-precipitation","volume":"403","author":"Zhang","year":"2023","journal-title":"Food Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:20:05Z","timestamp":1780172405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0925443926001432"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168280","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1\/JUN","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168280"}}